Market Trends Regenxbio up 4% following additional data on Duchenne gene therapy assetBy admin8996erT0allMarch 19, 2025 Hailshadow/iStock via Getty Images Regenxbio (NASDAQ:RGNX) is up ~4% in Wednesday morning trading after releasing additional biomarker data from the…
